Success Metrics

Clinical Success Rate
73.3%

Based on 11 completed trials

Completion Rate
73%(11/15)
Active Trials
3(13%)
Results Posted
9%(1 trials)
Terminated
4(17%)

Phase Distribution

Ph not_applicable
11
48%
Ph phase_3
2
9%
Ph phase_2
1
4%
Ph phase_4
7
30%

Phase Distribution

0

Early Stage

1

Mid Stage

9

Late Stage

Phase Distribution21 total trials
Phase 2Efficacy & side effects
1(4.8%)
Phase 3Large-scale testing
2(9.5%)
Phase 4Post-market surveillance
7(33.3%)
N/ANon-phased studies
11(52.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

68.8%

11 of 16 finished

Non-Completion Rate

31.3%

5 ended early

Currently Active

3

trials recruiting

Total Trials

23

all time

Status Distribution
Active(4)
Completed(11)
Terminated(5)
Other(3)

Detailed Status

Completed11
Terminated4
unknown3
Recruiting3
Not yet recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
23
Active
3
Success Rate
73.3%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (4.8%)
Phase 32 (9.5%)
Phase 47 (33.3%)
N/A11 (52.4%)

Trials by Status

completed1148%
not_yet_recruiting14%
terminated417%
unknown313%
recruiting313%
withdrawn14%

Recent Activity

Clinical Trials (23)

Showing 20 of 23 trialsScroll for more
NCT06959524Not Applicable

AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions

Recruiting
NCT07397845Not Applicable

Stents Versus PAclitaxel Coated Balloons for Revascularization of CompleX and Small Coronary Vessels (SPARX) Trial

Not Yet Recruiting
NCT07229248Phase 3

DCB vs. DES in Young STEMI Patients: The DCB-STEMI Trial

Recruiting
NCT05780359Not Applicable

Evaluating the Safety and Efficacy of the G-stream® Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery

Recruiting
NCT04753827Not Applicable

"L-Sandwich" Strategy in the True Coronary Bifurcation Lesions

Completed
NCT02594501Not Applicable

Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy

Unknown
NCT01574534Not Applicable

Basel Stent Kosten Effektivitäts Trial Drug Eluting Balloons vs. Drug Eluting Stents in Small Vessel Interventions

Completed
NCT03033862

Thrombogenicity Assessment in Patients Treated With Bioresorbable Vascular Scaffolds

Withdrawn
NCT03610347Not Applicable

Paclitaxel Eluting Balloon After Bare Metal Stent Implantation vs. Drug-Eluting Stent in St Elevation Myocardial Infarction

Terminated
NCT01122719Not Applicable

Brazilian and Italian Evaluation of Safety Using Tacrolimus-eluting Stent With Short-term Dual Antiplatelet Regimen

Terminated
NCT02760732Not Applicable

Drug Eluting Balloon for Treatment of Unstable Angina

Unknown
NCT00856765Phase 2

Drug-eluting Balloon in Acute Myocardial Infarction

Completed
NCT01093391Phase 3

A Trial of Bare Metal Stent - Cobalt Chromium Versus Stent Coating With Sirolimus

Completed
NCT00595647Phase 4

Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions

Terminated
NCT01899235Phase 4

The Treatment of Coronary De-novo Lesions With the Elutax Paclitaxel-eluting Balloon Alone, a Pilot Study

Terminated
NCT01956448Not Applicable

SORT-OUT VI - Randomized Clinical Comparison of Biomatrix Flex® and Resolute Integrity®

Completed
NCT00388934Phase 4

Comparison of Cypher Select and Taxus Express Coronary Stents

Completed
NCT01867034Not Applicable

Soluble Receptors for Advanced Glycation End-Products and PCI

Unknown
NCT00640770Phase 4

Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease

Completed
NCT00552669Phase 4

Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents

Completed

Drug Details

Intervention Type
DEVICE
Total Trials
23